* Helius Medical Technologies Inc HSDT.OQ reported a
quarterly
adjusted loss of 17 cents per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 13 cents per share.
* Revenue rose 9.3% to $282.00 thousand from a year ago;
analysts
expected $259.00 thousand.
* Helius Medical Technologies Inc's reported EPS for the
quarter
was a loss of 17 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Helius Medical Technologies Inc shares had fallen by 7.5%
this
quarter.
* The company reported a quarterly loss of $4.89 million.
* Wall Street's median 12-month price target for Helius
Medical
Technologies Inc is $2.25
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 9 at 10:54 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.13 -0.17 Missed
Sep. 30 2022 -0.21 -0.03 Beat
Jun. 30 2022 -1.12 -0.97 Beat
Mar. 31 2022 -1.13 -1.15 Missed